Uffe Heide-Jørgensen Selected Research

Ranitidine (Zantac)

3/2022	Correction: Ranitidine Use and Risk of Upper Gastrointestinal Cancers.
1/2022	Ranitidine Use and Risk of Upper Gastrointestinal Cancers-Reply.
1/2022	Ranitidine and Risk of Bladder and Kidney Cancer: A Population-Based Cohort Study.
12/2021	Ranitidine Use and Risk of Upper Gastrointestinal Cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Uffe Heide-Jørgensen Research Topics

Disease

9	Neoplasms (Cancer) 01/2022 - 01/2015
7	Breast Neoplasms (Breast Cancer) 03/2021 - 10/2015
3	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 03/2022 - 12/2021
3	Kidney Diseases (Kidney Disease) 01/2022 - 01/2021
3	Osteonecrosis (Kienbock's Disease) 11/2021 - 01/2016
2	Hemorrhage 11/2022 - 01/2019
2	Pancreatic Neoplasms (Pancreatic Cancer) 12/2021 - 01/2020
2	Pain (Aches) 11/2021 - 10/2015
2	COVID-19 01/2021 - 10/2020
2	Anemia 02/2020 - 01/2020
1	Ischemic Stroke 11/2022
1	Coronary Artery Disease (Coronary Atherosclerosis) 11/2022
1	Myocardial Infarction 11/2022
1	Kidney Neoplasms (Kidney Cancer) 01/2022
1	Bone Fractures (Bone Fracture) 11/2021
1	Albuminuria 01/2021
1	Human Influenza (Influenza) 10/2020
1	Pneumonia (Pneumonitis) 10/2020
1	Multiple Endocrine Neoplasia Type 2a (MEN 2) 02/2020
1	Pancreatitis 01/2020
1	Atrial Fibrillation 01/2019
1	Osteoporotic Fractures 01/2019
1	Neoplasm Metastasis (Metastasis) 01/2016
1	Infections 01/2016
1	Lung Diseases (Lung Disease) 01/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2015
1	Premature Birth (Birth, Premature) 01/2015
1	Neonatal Abstinence Syndrome 01/2015
1	Obesity 01/2015
1	Pregnancy Complications 01/2015
1	Ulcer 01/2015

Drug/Important Bio-Agent (IBA)

4	Ranitidine (Zantac)FDA LinkGeneric 03/2022 - 12/2021
4	Denosumab FDA Link 11/2021 - 01/2016
3	CreatinineIBA 01/2022 - 01/2021
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2022 - 08/2020
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2022 - 01/2016
2	omega-Chloroacetophenone (Mace)IBA 11/2022 - 02/2020
2	Zoledronic Acid (Zometa)FDA Link 11/2021 - 01/2016
2	Angiotensin Receptor AntagonistsIBA 01/2021 - 10/2020
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 10/2020
2	Hemoglobins (Hemoglobin)IBA 02/2020 - 01/2020
2	Prescription DrugsIBA 01/2020 - 01/2015
2	Opioid Analgesics (Opioids)IBA 10/2015 - 01/2015
1	Proton Pump InhibitorsIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 03/2021
1	AlbuminsIBA 01/2021
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 10/2020
1	Aromatase InhibitorsIBA 08/2020
1	Estrogen ReceptorsIBA 08/2020
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 01/2019
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2019
1	AnticoagulantsIBA 01/2019
1	Vitamin K FDA Link 01/2019
1	Diphosphonates (Bisphosphonates)IBA 10/2017
1	Bone Density Conservation AgentsIBA 01/2016
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2016
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2016
1	Morphine (MS Contin)FDA LinkGeneric 10/2015
1	Pharmaceutical PreparationsIBA 10/2015
1	Methadone (Dolophine)FDA LinkGeneric 01/2015
1	Buprenorphine (Subutex)FDA LinkGeneric 01/2015
1	nasIBA 01/2015
1	oxidized low density lipoproteinIBA 01/2015
1	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2015
1	Heroin (Diamorphine)IBA 01/2015

Therapy/Procedure

5	Therapeutics 03/2021 - 01/2016
4	Neoadjuvant Therapy 03/2021 - 12/2019